Vimkunya
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Vimkunya, covering 2025-01-31 to 2025-08-22. Get the full timeline:
Most recent: EMA Authorised: Vimkunya (Chikungunya virus (CHIKV) virus-like particle (VLP) proteins (capsid protein (C) and envelope proteins E1 and E2) derived from CHIKV Senegal strain 37997 produced in human embryonic kidney cells by recombinant DNA technology, adsorbed on aluminium hydroxide, hydrated) — Bavarian Nordic A/S